Thyroid Carcinoma Clinical Trials

47 clinical trials for Thyroid Carcinoma across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma — RECRUITING · NA
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies — RECRUITING · PHASE1
• Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma — RECRUITING · PHASE1
• CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma — RECRUITING
• Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy — RECRUITING
• Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia — RECRUITING
• An International Study on Pediatric Patients With Rare Tumors. — RECRUITING
• The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery — RECRUITING · NA
• Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas — RECRUITING
• International PPB/DICER1 Registry — RECRUITING
• Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology — RECRUITING
• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC — RECRUITING · PHASE2
• Function Integrity of Neck Anatomy in Thyroid Surgery — RECRUITING · NA
• Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma — COMPLETED · PHASE2
• Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib — ACTIVE_NOT_RECRUITING
• Thyroid Cancer and Sunitinib — COMPLETED · PHASE2
• Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) — ACTIVE_NOT_RECRUITING · PHASE2
• Study of IK-595 in RAS- or RAF-altered Advanced Tumors — TERMINATED · PHASE1
• Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers — COMPLETED · PHASE1
• More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated — COMPLETED
• Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study — COMPLETED · PHASE1
• Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW — COMPLETED · PHASE1
• Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System — TERMINATED · PHASE2
• OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults — OTHER · PHASE4
• European Multicenter Study on Surgical Management of Advanced Thyroid Cancer — OTHER
• Optimising Molecular Radionuclide Therapy — COMPLETED
• Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine — COMPLETED
• Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer — COMPLETED · NA
• Cell-free Tumor DNA in Head and Neck Cancer Patients — OTHER · NA
• The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma — WITHDRAWN · NA
• Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases — OTHER
• Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer — COMPLETED
• Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma — COMPLETED · PHASE2
• Trial of LBH589 in Metastatic Thyroid Cancer — COMPLETED · PHASE2
• Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection — OTHER · NA
• Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients — COMPLETED · PHASE2
• A Study Into the Effect of Seprafilm in Open Total Thyroidectomy — TERMINATED · NA
• Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function — COMPLETED
• Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm — COMPLETED
• Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies — COMPLETED · PHASE1
• Lipid Metabolic Status in Thyroid Carcinoma — COMPLETED
• Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain — COMPLETED · PHASE3
• Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer — TERMINATED · PHASE2
• Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma — OTHER · NA
• Influence of Thyroid Hormones on the Woundhealing Process — OTHER · NA
• Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases — OTHER · NA

Refine this search